Immunotherapy for glioma: getting closer to the clinical arena? Nov 2011 - Curr. Opin. Neurol.; 24(6):1473-6551 [PMID:22027543] [Finocchiaro G] [Pellegatta S]
Immunotherapy in human glioblastoma. Sep 2011 - Rev. Neurol. (Paris); 167(10):0035-3787 [PMID:21885075] [Szabo AT] [Carpentier AF]
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus Sep 2011 - 2011 ASCO Annual Meeting; Oral Abstract Session, Developmental Therapeutics - Clinical Pharmacology and Immunotherapy [Nesselhut ]
Immuntherapie des Glioblastoma multiforme mit dendritischen Zellen Sep 2011 - Dissertation [Beez ]
New Perspectives in Glioma Immunotherap. Aug 2011 - :1873-4286 [PMID:21827420] [Daga A] [Bottino C] [Castriconi R] [Gangemi R] [Ferrini S]
Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design. Jul 2011 - Clin. Cancer Res.; 17(14):1078-0432 [PMID:21632862] [Mineharu Y] [King GD] [Muhammad AG] [Bannykh S] [Kroeger KM] [Liu C] [Lowenstein PR] [Castro MG]
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy. Apr 2011 - :1537-4513 [PMID:21499132] [Fadul CE] [Fisher JL] [Hampton TH] [Lallana EC] [Li Z] [Gui J] [Szczepiorkowski ZM] [Tosteson TD] [Rhodes CH] [Wishart HA] [Lewis LD] [Ernstoff MS]
Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Mar 2011 - Clin. Cancer Res.; 17(6):1078-0432 [PMID:21135147] [Prins RM] [Soto H] [Konkankit V] [Odesa SK] [Eskin A] [Yong WH] [Nelson SF] [Liau LM]
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. Jan 2011 - J. Clin. Oncol.; 29(3):1527-7755 [PMID:21149657] [Okada H] [Kalinski P] [Ueda R] [Hoji A] [Kohanbash G] [Donegan TE] [Mintz AH] [Engh JA] [Bartlett DL] [Brown CK] [Zeh H] [Holtzman MP] [Reinhart TA] [Whiteside TL] [Butterfield LH] [Hamilton RL] [Potter DM] [Pollack IF] [Salazar AM] [Lieberman FS]
Dendritic cell vaccines to combat glioblastoma. Apr 2010 - Expert Rev Neurother; 10(4):1744-8360 [PMID:20367199] [Wheeler CJ]
Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination. Jan 2010 - J. Immunol. Methods; 352(1-2):1872-7905 [PMID:19874827] [Ardon H] [Verbinnen B] [Maes W] [Beez T] [Van Gool S] [De Vleeschouwer S]
Dendritic cell vaccines for brain tumors. Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944973] [Kim W] [Liau LM]
Heat shock proteins in glioblastomas. Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944971] [Yang I] [Fang S] [Parsa AT]
Monitoring immune responses after glioma vaccine immunotherapy. Nov 2009 - Neurosurg. Clin. N. Am.; 21(1):1558-1349 [PMID:19944978] [Jian B] [Yang I] [Parsa AT]
Heat-shock protein vaccines as active immunotherapy against human gliomas. Nov 2009 - Expert Rev Anticancer Ther; 9(11):1744-8328 [PMID:19895242] [Yang I] [Han S] [Parsa AT]
